LOTTE Holdings Co., Ltd. (Tokyo, Japan; CEO: Genichi Tamatsuka, hereinafter “LOTTE Holdings”) announces an investment in Metaphore Biotechnologies, Inc. (Headquarters: Cambridge, MA, USA; CEO: Angela ...

There's a change at the helm of Johnson & Johnson's pharma division in the offing, as executive vice president Jennifer ...

BROADEN2 Phase 2b AD trial nearly six months ahead of anticipated timeline, with data expected by year-end 2026 ...

Johnson & Johnson named Tom Cavanaugh to lead Innovative Medicine as Jennifer Taubert retires after more than 21 years with J ...

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a fully integrated, commercial-stage ...

Lymphocytes are central orchestrators of immune responses, integrating signals from activating and inhibitory receptors, cytokines, and metabolic pathways ...

As we age, chronic inflammation-or "inflammaging"-increases throughout the body and weakens our ability to fight cancer.

Macrophages formed in the bone marrow can only assume the function of embryonal phagocytes, or "scavenger cells," to a certain degree according to a study by the University of Bonn and the Peter ...

A massive analysis of immune cells in human tissue is yielding clues to the root causes of lung and autoimmune diseases.

Johnson & Johnson has named Tom Cavanaugh as the next leader of its innovative medicines business, beginning Sept. 1, 2026.

Patients with recurrent respiratory tract infections receiving Broncho-Vaxom, a bacterial lysate-based therapy, had lower ...

AbbVie Inc. stock fell 6.2% after a 52-week high despite strong Q2 earnings; Rinvoq and Elahere sales surged. Click for this ...